Log in to your client extranet for free matter information, know-how and documents.
Mills & Reeve system for employees.
One of the UK’s largest founder-owned nursery groups, with over 20 settings across the East of England and East London, has been acquired by AcadeMedia, marking the Swedish education group's entry into the UK early years market.
Goya Developments and Hillwood (a Perot Company) have completed the first letting at the Swanley Distribution Park site in the Sevenoaks district of Kent.
Our corporate team advised IQ Capital and Northern Gritstone on their participation in a £5 million seed funding round for Imperagen, a biotech company focused on advancing enzyme engineering.
Eight principal associates have been promoted to partners, effective from 1 June 2026, taking the total number of partners to 195 across the firm’s seven offices.
Our corporate team has advised AppCheck on securing a minority investment from LDC, part of Lloyds Banking Group, to support the cybersecurity software company's expansion and continued product development.
Our corporate team have advised on the sale of leading international fertility services provider, TFP Fertility, to a US private equity investor.
We've retained our Investors in People (IiP) platinum accreditation – a standard achieved by only 8% of assessed organisations.
We've advised the University of Sussex on its successful appeal against a record fine for breaching free speech.
We've strengthened our national commercial team with the appointment of senior industry specialist, Fiona Teague.
We're pleased to announce our sponsorship of the inaugural Ox Tech Week, taking place from 26 to 29 May, supporting a landmark event that will shine a spotlight on Oxford’s world leading innovation ecosystem.
We've become the first Midlands-based company to join the UK SCALE Centre’s flagship membership network, The Supply Chain Futures Forum.
Our team has advised the shareholders of Owen Mumford Holdings Limited on its agreement for the sale to embecta Corp. (Nasdaq: EMBC), a global leader in diabetes care technology, in a transaction valued at up to £150 million.